Endothelial injury of capillaries in the stria vascularis of guinea pigs treated with cisplatin and gentamicin.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Ultrastructural Pathology

• Publication date

  1997-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/01913129709021925PMID 9183830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cisplatin-induced ototoxicity: Audiometric findings and experimental cochlear pathology

  2004cited by this paper
• Cisplatin metabolites and their toxicity on isolated cochlear outer hair cells in vitro.

  1996cited by this paper
• Vascular toxicity associated with chemotherapy and hormonotherapy.

  1994cited by this paper
• Comparative ototoxicity of cisplatin during acute and chronic treatment.

  1994cited by this paper
• Severe vascular toxicity associated with cisplatin‐based chemotherapy

  1993cited by this paper
• Vascular toxicity associated with antineoplastic agents.

  1992cited by this paper
• Toxic effects of cisplatin alone and in combination with gentamicin in stria vascularis of guinea pigs

  1991cited by this paper
• Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration.

  1991cited by this paper
• Formation of a cytotoxic metabolite from gentamicin by liver.

  1990cited by this paper
• Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis

  1988cited by this paper
• Human cochlear pathology in aminoglycoside ototoxicity--a review.

  1987cited by this paper
• Endothelial injury caused by antineoplastic agents.

  1986cited by this paper
• Mitochondrial alterations in cisplatin-induced acute renal failure.

  1986cited by this paper
• Aortic pressure as a determinant of cardiac protein degradation.

  1986cited by this paper
• Cis-diaminedichloro platinum ototoxicity. An experimental study.

  1985cited by this paper
• Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin

  1985cited by this paper
• Results of an ultrastructural study comparing stria vascularis with organ of Corti in guinea pigs treated with kanamycin.

  1985cited by this paper
• Ototoxic and Nephrotoxic Effects of Combined Treatment with cis-Diamminedichloroplatinum and Kanamycin in the Guinea Pig

  1984cited by this paper
• Ototoxicity of the anticancer drug cisplatin. An experimental study.

  1982cited by this paper
• Rapid onset hearing loss after Cisplatinum therapy: Case reports and literature review

  1982cited by this paper
• Cis-Diamminedichloroplatinum (II) Ototoxicity in the Guinea Pig

  1981cited by this paper
• Cis-platinum associated hearing loss

  1981cited by this paper
• Aminoglycoside ototoxicity.

  1980cited by this paper
• A Randomized Comparative Trial of Three Aminoglycosides—Comparison of Continuous Infusions of Gentamicin, Aaikacin and Sisomicin Combined with Carbenicillin in the Treatment of Infections in Neutropenic Patients with Malignancies

  1979cited by this paper
• cis-Platinum ototoxicity.

  1978cited by this paper
• Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig.

  1975cited by this paper
• Cis-dichlorodiammineplatinum (II) (NSC-119875): hearing loss and other toxic effects in rhesus monkeys.

  1975cited by this paper
• Ultrastructural pathology of the cell: A text and atlas of physiological and pathological alterations in cell fine structure

  1975cited by this paper
• Blockage of the cochlear aqueduct.

  1974cited by this paper
• Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man.

  1974cited by this paper
• Ultrastructure of toe cochlear blood vessels.

  1974cited by this paper

• IFNγ blockade in capillary leak site improves tumour chemotherapy by inhibiting lactate-induced endocytosis of vascular endothelial-cadherins

  2023cites this paper
• Diabetes Mellitus and Hearing Loss: A Review.

  2021cites this paper
• Thrombotic Microangiopathy: Multi-Institutional Review of Pediatric Patients Who Underwent HSCT

  2021cites this paper
• Andrographolide suppresses cisplatin-induced endothelial hyperpermeability through activation of PI3K/Akt and eNOS -derived nitric oxide.

  2020cites this paper
• Non-invasive detection of severe neutropenia in chemotherapy patients by optical imaging of nailfold microcirculation

  2018cites this paper
• Cardiovascular baroreflex sensitivity attenuates by cisplatin-induced toxicity in rats

  2015cites this paper
• Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study

  2015cites this paper
• Silencing of PKC-α, TRPC1 or NF-κB expression attenuates cisplatin-induced ICAM-1 expression and endothelial dysfunction.

  2015cites this paper
• Hypomagnesemia and cisplatin nephrotoxicity

  2015cites this paper
• Renal and Cardiovascular Damage Induced by Cisplatin in Rats

  2014cites this paper
• Skeletal and metabolic complications of testicular germ cell tumours.

  2014cites this paper
• Vitamin C dose-dependently ameliorates renal hemodynamic toxicity of cisplatin in adult Swiss albino rats: a histopathologic and biochemical study

  2014cites this paper
• Propofol protects human umbilical vein endothelial cells from cisplatin-induced injury.

  2014cites this paper
• Abdominal visceral and subcutaneous fat increase, insulin resistance and hyperlipidemia in testicular cancer patients treated with cisplatin-based chemotherapy

  2014cites this paper
• Vitamin E Is a Nephroprotectant Agent in Male but Not in Female in a Model of Cisplatin-Induced Nephrotoxicity

  2013cites this paper
• Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications.

  2012cites this paper
• Thrombotic Microangiopathy in Haematopoietic Stem Cell Transplantation

  2012cites this paper
• The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect

  2012influential citation
• The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: Gender related differences in rat model

  2011cites this paper
• Protective effects of Salvia miltiorrhiza against cisplatin-induced ototoxicity in guinea pigs.

  2011cites this paper
• Does cisplatin-based chemotherapy effect on blood lipid levels of patients with germ cell testicular tumor in long-term follow-up?

  2011cites this paper
• Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro.

  2009cites this paper
• Cisplatin up‐regulates ICAM‐1 expression in endothelial cell via a NF‐κB dependent pathway

  2008cites this paper
• Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?

  2007cites this paper
• Long-term complications of platinum-based chemotherapy in testicular cancer survivors

  2007cites this paper
• Gene Expression Analysis of Hepatic Response Induced by Gentamicin in Mice

  2007cites this paper
• Hepatotoxicity of Combined Treatment with Cisplatin and Gentamicin in the Guinea Pig

  2005cites this paper
• Expression of vascular endothelial growth factor and its receptors in the cochlea of various experimental animals

  2005cites this paper
• In vitro endothelial cell susceptibility to xenobiotics: Comparison of three cell types

  2005cites this paper
• Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid.

  2005cites this paper
• Perilymphatic application of α-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin

  2004cites this paper
• Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow.

  2003cites this paper
• Expression of caspase-activated deoxyribonuclease (CAD) and caspase 3 (CPP32) in the cochlea of cisplatin (CDDP)-treated guinea pigs.

  2003cites this paper
• Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice.

  2002cites this paper
• The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures.

  2002cites this paper
• Carboplatin Induces Less Apoptosis in the Cochlea of Guinea Pigs than Cisplatin

  2002cites this paper
• Nephrotoxicity of Combined Treatment with Cisplatin and Gentamicin in the Guinea Pig: Glomerular Injury Findings

  2002cites this paper
• Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity.

  2002cites this paper
• Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.

  2000cites this paper
• D-Methionine protects against cisplatin damage to the stria vascularis.

  1999cites this paper
• Perivascular amorphous matrices containing laminin and type IV collagen not organized as a conventional basal lamina: identification by electron microscopy and implications for the control of cell biological processes.

  1999cites this paper